Columbia University

Heinemann To Publish New Professional Book By EduColor Co-Founder José Luis Vilson

Retrieved on: 
Wednesday, March 20, 2024
Knowledge, Narrative, Syracuse University, Education, Learning, Philosophy, Teacher, Policy, Columbia University, Human, Student, Mathematics, Sociology, Vilson, City college, Teaching

PORTSMOUTH, N.H., March 20, 2024 /PRNewswire/ -- Heinemann today announced that it will publish the latest professional book for teachers from award-winning author and speaker José Luis Vilson.

Key Points: 
  • PORTSMOUTH, N.H., March 20, 2024 /PRNewswire/ -- Heinemann today announced that it will publish the latest professional book for teachers from award-winning author and speaker José Luis Vilson.
  • The project, called You Already Know: Teaching Students Math from The Knowledge Within, is tentatively scheduled for publication in spring 2025.
  • Vilson is the co-founder and executive director of EduColor, an organization dedicated to race and social justice issues in education.
  • "We have long admired José's work and insight on topics across education, math and equity," said Maggie DeMont, general manager of Heinemann.

Dow Jones and Columbia Journalism School Announce London Expansion of HBCU Media Collective

Retrieved on: 
Tuesday, March 19, 2024
Community, Inclusion, Sun, Dow Jones, Talksport, Partnership, Barron's, Virgin Radio, Howard University, SVP, Travel, Journal, The Sun, News, Columbia University, Editorial, Collective, Faculty, News Corp, Radio, Student, Morehouse College, HBCU, MarketWatch, Spelman College, Morgan State University, Times Radio, The Wall Street Journal, Florida A&M University, Journalism, The, Nursing

NEW YORK, March 19, 2024 /PRNewswire/ -- Dow Jones, a global provider of news and business information, and Columbia Journalism School today announced the expansion of the annual Historically Black Colleges and Universities (HBCU) Media Collective. Now in its second year, the HBCU Media Collective has added an international component to boost students' awareness of global opportunities while enhancing newsroom diversity and promoting financial literacy for participating students.

Key Points: 
  • NEW YORK, March 19, 2024 /PRNewswire/ -- Dow Jones, a global provider of news and business information, and Columbia Journalism School today announced the expansion of the annual Historically Black Colleges and Universities (HBCU) Media Collective.
  • "Our continued partnership with Dow Jones offers a dynamic, transformative opportunity to a second cohort of students," said Dr. Jelani Cobb, Dean of the Columbia Journalism School.
  • "The expansion of the HBCU Media Collective underscores the shared commitment we have with Columbia in developing bespoke learning opportunities to identify and mentor the next generation of aspiring journalists," said Brent Jones, SVP of Training, Culture & Community at Dow Jones.
  • The HBCU Media Collective is one of many opportunities Dow Jones offers to encourage careers in financial journalism and as part of its commitment to building an even stronger workplace culture.

For a Bright Future Foundation's Annual Fundraiser Successfully Raises $400,000, Advancing its Mission to Make a Positive Impact

Retrieved on: 
Monday, March 18, 2024
Organization, Entrepreneurship, Emmy Awards, Education, WWE, Committee, Columbia University, Seed, Student, STEAM, Investment, Exhibition, Heart, Actor, BECU, Nursing

MIAMI, March 18, 2024 /PRNewswire/ -- Louis Hernandez Jr.'s Foundation For A Bright Future ("For A Bright Future," "FABF"), a non-profit organization dedicated to supporting underprivileged and underprivileged children, has successfully raised $400,000 during their March 14th fundraiser. This event, held in the heart of New York City, aimed to benefit the Foundation's scholarships and STEAM project-based programs.

Key Points: 
  • This remarkable backing will enable For A Bright Future to take substantial steps forward in furthering its mission and creating a positive impact in underserved communities nationwide.
  • "The success of our recent fundraiser is a testament to the unwavering commitment of our community to create a positive impact.
  • Motivated by this realization, he founded For A Bright Future to support deserving students and give back to the community.
  • To explore sponsorship opportunities and discover how you can make a meaningful impact, please reach out to us at [email protected] .

Award-winning Guardian U.S. journalist Margaret Sullivan to be keynote speaker at annual World Press Freedom Day Luncheon, May 2

Retrieved on: 
Monday, March 18, 2024
Journalism, Freedom, Democracy, The Washington Post, Ethics, Student, The New York Times, WPFC, Career Achievement Award, National Arts Centre, World Press Freedom Day, United Nations, History, Social media, EDT, Politics, Columbia University, UNESCO, Commission, Safety, Security, Guardian, Artificial intelligence

These elections are taking place against a backdrop of a global democratic decline, which threatens human rights including media freedom.

Key Points: 
  • These elections are taking place against a backdrop of a global democratic decline, which threatens human rights including media freedom.
  • The protection of a free press is a critical component for a healthy democracy, says UNESCO, the United Nations agency that established May 3 as World Press Freedom Day in 1993.
  • Career Achievement Award in honour of Spencer Moore, which honours a Canadian journalist who has demonstrated ongoing tenacity in pursuit of press freedom and freedom of information.
  • A new Student Achievement Award, given to a student journalist who overcame press freedom challenges in producing outstanding work for a media platform.

Gilgamesh Pharmaceuticals Awarded $14 Million National Institute on Drug Abuse Grant to Advance Novel, Cardiac-Safe Ibogaine Analog for the Treatment of Opioid Use Disorder

Retrieved on: 
Thursday, March 14, 2024
Patient, Public, OUD, Research, Columbia University, Opioid use disorder, IND, GMP, Report, Ibogaine, Toxicology, Pharmaceutical industry

NEW YORK, March 14, 2024 /PRNewswire/ -- Gilgamesh Pharmaceuticals, a clinical-stage neuroscience company committed to developing best-in-class, rapid-acting treatments for mental health disorders, today announced that it has been awarded a multi-year $14 million grant from the National Institute on Drug Abuse (NIDA) to develop GM-3009, its novel, cardiac-safe ibogaine analog for the treatment of substance use disorders. As summarized in a recent New York Times article (Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction), ibogaine, a plant-derived psychoactive compound, has accumulated data from trials and case reports that point to its robust efficacy as a treatment for substance use disorders. However, the development of ibogaine as a pharmaceutical has long been hindered by its significant cardiovascular toxicity.

Key Points: 
  • However, the development of ibogaine as a pharmaceutical has long been hindered by its significant cardiovascular toxicity.
  • This grant provides non-dilutive funding to support IND-enabling toxicology studies, GMP manufacturing, and Phase 1/1b clinical trials in healthy volunteers and opioid use disorder (OUD) patients for GM-3009.
  • The planned clinical work will seek to confirm that GM-3009 eliminates the cardiovascular risks associated with ibogaine and demonstrate proof-of-concept efficacy in attenuating symptoms associated with OUD.
  • As Gilgamesh moves forward with its clinical trials, the company is poised to lead a new era in addiction treatment, marked by safer, more effective, and scientifically validated therapies.

Madrigal Announces Groundbreaking Ketamine Research for PTSD Treatment and Upcoming In-Human Clinical Trials

Retrieved on: 
Wednesday, March 13, 2024
Depression, Organization, Learning, Post-traumatic stress disorder, Research, Trauma, Anxiety, Columbia University, Human, Disorder, FDA, Pharmaceutical industry

This groundbreaking study marks the beginning of a new chapter, as Madrigal gears up to initiate in-human clinical trials.

Key Points: 
  • This groundbreaking study marks the beginning of a new chapter, as Madrigal gears up to initiate in-human clinical trials.
  • The research underscores the potential of Ketamine combined with Madrigal's proprietary nanotechnology to offer a transformative approach to PTSD treatment, aiming to address the core of the trauma rather than merely managing symptoms.
  • Madrigal, originating from Kibbutz Re'im in Israel's south, has been dedicated to combating PTSD, a commitment that has intensified in the wake of these events.
  • With a commitment to redefining mental health treatment, Madrigal is poised to make a significant impact on the lives of those affected by PTSD.

Interise Welcomes Two New Board Members In 20th Year

Retrieved on: 
Wednesday, March 13, 2024
Steps, Principal, MIT, Lead, Harvard Business School, Economic development, Columbia University, University, NYU, Small business, MBA, Woman, Streetwise, Barclays, School, Management

Over the last two decades, Interise has supported over 10,000 small businesses in 80 communities on building resiliency and growth.

Key Points: 
  • Over the last two decades, Interise has supported over 10,000 small businesses in 80 communities on building resiliency and growth.
  • Interise companies are growing at an average of 38%, and they are responsible for creating close to 250,000 jobs.
  • I am excited to join my fellow board members in creating more equitable and inclusive economic opportunities, and as Interise celebrates its 20th year, I'm proud to continue its legacy in pursuing an economy that works for all."
  • The Interise Board Chair is Tyrone Foster, owner and CEO of Portland-based Precision Landscape Services, Inc.

The Huntington National Bank Announces Retirement of Raj Syal, Chief Human Resources Officer; Sarah Pohmer Joins as Successor

Retrieved on: 
Wednesday, March 13, 2024
Bank of America, Huntington Bancshares, University, HR, S&P Global, Toronto-Dominion Bank, Bank, Columbia University, Head, Human, Commerce, Psychology, JPMorgan Chase, Human resources, Training and development, Management

COLUMBUS, Ohio, March 13, 2024 /PRNewswire/ -- The Huntington National Bank ("Huntington") today announced that Raj Syal, Chief Human Resources Officer, will retire Oct. 1, 2024, and will be succeeded by Sarah Pohmer, effective May 6.

Key Points: 
  • COLUMBUS, Ohio, March 13, 2024 /PRNewswire/ -- The Huntington National Bank ("Huntington") today announced that Raj Syal, Chief Human Resources Officer, will retire Oct. 1, 2024, and will be succeeded by Sarah Pohmer, effective May 6.
  • Prior to joining Huntington in 2015, he was Chief Human Resources Officer for Markit, a financial information services business that is now part of S&P Global.
  • Pohmer was previously with JPMorgan Chase for 24 years, most recently in the role of Managing Director, Head of Human Resources for the Consumer Bank.
  • Prior to that role, she was Head of Human Resources for Cards and Connected Commerce, and, previously, Head of Human Resources for Business Banking and Staff Functions.

Hummingbird Bioscience and Dartmouth's Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024

Retrieved on: 
Wednesday, March 13, 2024
DVM, Head, Q&A, Entrepreneurship, Immunotherapy, Patient, Triple-negative breast cancer, Immunology, Geisel School of Medicine, Columbia University, Cancer, Doctor of Philosophy, MD, Lung cancer, Yale School of Medicine, Neoplasm, Physician, VISTA, Management

SINGAPORE and HANOVER, Germany, March 13, 2024 /PRNewswire/ -- Hummingbird Bioscience and Dartmouth's Geisel School of Medicine today announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024 (11:00 AM - 3:30 PM ET).

Key Points: 
  • SINGAPORE and HANOVER, Germany, March 13, 2024 /PRNewswire/ -- Hummingbird Bioscience and Dartmouth's Geisel School of Medicine today announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024 (11:00 AM - 3:30 PM ET).
  • High VISTA expression in tumor correlates with poor survival in cancer patients and has been associated with a lack of response to other immune checkpoint inhibitors.
  • Pre-clinical data on VISTA biology and VISTA targeting have shown potent anti-tumor effects, and clinical readouts are expected this year.
  • The symposium will explore the important role of VISTA in cancer immunotherapy.

Hummingbird Bioscience and Dartmouth's Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024

Retrieved on: 
Wednesday, March 13, 2024
DVM, Head, Q&A, Entrepreneurship, Immunotherapy, Patient, Triple-negative breast cancer, Immunology, Geisel School of Medicine, Columbia University, Cancer, Doctor of Philosophy, MD, Lung cancer, Yale School of Medicine, Neoplasm, Physician, VISTA, Management

SINGAPORE and HANOVER, Germany, March 13, 2024 /PRNewswire/ -- Hummingbird Bioscience and Dartmouth's Geisel School of Medicine today announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024 (11:00 AM - 3:30 PM ET).

Key Points: 
  • SINGAPORE and HANOVER, Germany, March 13, 2024 /PRNewswire/ -- Hummingbird Bioscience and Dartmouth's Geisel School of Medicine today announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024 (11:00 AM - 3:30 PM ET).
  • High VISTA expression in tumor correlates with poor survival in cancer patients and has been associated with a lack of response to other immune checkpoint inhibitors.
  • Pre-clinical data on VISTA biology and VISTA targeting have shown potent anti-tumor effects, and clinical readouts are expected this year.
  • The symposium will explore the important role of VISTA in cancer immunotherapy.